WASHINGTON, D.C. – Today, the U.S. Chamber Global Innovation Policy Center (GIPC) launched its Discover and Deliver initiative to show what the nation’s brightest scientific minds and most innovative companies are doing to discover effective treatments and cures for COVID-19, outlined in an interactive map which depicts where COVID-19-related innovations are being developed in the United States.
The map reveals that there are currently 560 clinical trials of potential COVID-19 solutions in all 50 states, across 85 percent of congressional districts.
Discover and Deliver puts on full display the unprecedented scope and speed of what companies are actively doing to defeat COVID-19, and how policymakers can help accelerate the process by protecting intellectual property, removing trade barriers, like unnecessary tariffs and export bans, and encouraging strategic collaboration through public-private partnerships.
“When it comes to the fight against COVID-19, every community’s contribution counts,” said David Hirschmann, CEO of the U.S. Chamber GIPC. “This has to be, and is, an all-of-nation effort. In the United States alone, the size and scope of this effort is staggering. Our new interactive map we are launching today tells the story of that amazing scope in a visual, digestible way.”
The campaign kicked off with a virtual public event featuring leading voices from the business community, biopharma innovators, and those directing clinical trials in communities across the nation. It featured remarks from innovation industry leaders and academic experts, focused on how smart innovation policy can help accelerate progress in defeating coronavirus. Notable speakers include:
- Dr. Michelle McMurry-Heath, President & CEO, BIO,
- Dr. Michael T. Osterholm, PhD, MPH, Director of the Center for Infectious Disease Research and Policy (CIDRAP) and New York Times Bestselling Author Co-Author of Deadliest Enemy: Our War on Killer Germs
- Mark Olshaker, Emmy Award-Winning Filmmaker and New York Times Bestselling Co-Author of Deadliest Enemy: Our War on Killer Germs
- Dr. Ihor S. Sawczuk, MD FACS, President, Northern Region, Hackensack Meridian Health,
- Dr. Anu Osinusi, MD, MPH, Executive Director, Clinical Research, Gilead,
- Dr. Jamie Freedman, Senior Vice President, U.S. Medical Affairs, Genentech.
The Discover and Deliver campaign will also sponsor a series of virtual events to help disseminate information and hold space for discussion at the local level.
“It’s clear that collaboration will lead us toward vaccines, treatments, and cures and away from this pandemic,” said Hirschmann. “So, we need more opportunities to share conversations and exchange ideas. The Discover and Deliver campaign will bring together experts from both the private and public sector to do just that.”
The campaign’s next event will spotlight a local community’s efforts, inviting participants to consider a "boots on the ground” view of progress underway.
“Today’s event was a good reminder that we’re all in this together, and we all have a part to play,” said Hirschmann. “If we all play our parts, we can help ensure that the innovative discoveries happening today can be delivered to people tomorrow.”
Each week the U.S. Chamber spotlights companies on the front-line search for effective treatments and vaccines to combat COVID-19, to access the entire catalog of articles, visit the U.S. Chamber Global Innovation Policy Center’s Discover & Deliver page.